Medicare Coverage of Buprenorphine-Naloxone Film Surrounding Generic Entry
Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder.
Value-Based Payment in Implementing Evidence-Based Care: The Mental Health Integration Program in Washington State
Value-based payment improved fidelity to key elements of the Collaborative Care Model—an evidence-based mental health intervention—and improved patient depression outcomes in Washington state.
Generic Initiation and Antidepressant Therapy Adherence Under Medicare Part D
This study shows that generic initiation improves adherence to antidepressant therapy among Medicare patients and mitigates the negative effects of the Part D coverage gap.
